Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection

Canadian Journal of Microbiology

Volumn 54, Issue 6, 2008, Pages 435-440

  Yordanov, M ^a   Dimitrova, P ^a   Patkar, S ^b   Saso, L ^c   Ivanovska, N ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b NOVOZYMES A S   (Denmark)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apigenin; Berberine; Candida albicans; Ibogaine; Kaempferol

Indexed keywords

BIOCHEMICAL ENGINEERING; CELLS; DRUG THERAPY; ENZYME INHIBITION; ENZYMES; FOOD ADDITIVES; TELLURIUM COMPOUNDS; YEAST;

ALBICANS; APIGENIN; BERBERINE (BB); CANDIDA; CANDIDA ALBICANS; CELL WALL PROTEINS; EPITHELIAL CELLS; EXTRA-CELLULAR ENZYMES; FLAVONOID COMPOUNDS; HOST CELLS; IN-VITRO; KAEMPFEROL; LIPOLYTIC; PATHOLOGIC CONDITIONS; PROTEINASE ACTIVITY; VIRULENCE FACTORS;

ENZYME ACTIVITY;

APIGENIN; ASPARTIC PROTEINASE; BERBERINE; CELL MEMBRANE PROTEIN; IBOGAINE; KAEMPFEROL;

ENZYME ACTIVITY; FUNGAL DISEASE; INHIBITION; VIRULENCE; YEAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; IN VITRO STUDY; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SURVIVOR;

ALKALOIDS; ANIMALS; ANTIFUNGAL AGENTS; ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL WALL; EXTRACELLULAR SPACE; FEMALE; FLAVONOIDS; FUNGAL PROTEINS; HT29 CELLS; HUMANS; LIPASE; MALE; MICE; MICE, INBRED ICR;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 45149123692     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W08-029     Document Type: Article

References (24)

1. Andriole, V.T. 1999. The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. J. Antimicrob. Chemother. 44: 151-162. doi:10.1093/jac/44.2.151. PMID:10473222.
2. Cassone, A., De Bernardis, F., Mondello, F., Ceddia, T., and Agatensi, L. 1987. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis. 156: 777-783. PMID:3309073.
3. Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., and de Repentigny, L. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64: 4514-4519. PMID:8890200.
4. Cox, G.M., McDade, H.C., Chen, S.C., Tucker, S.C., Gottfredsson, M., Wright, L.C., et al. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39: 166-175. doi:10.1046/j.1365-2958.2001.02236.x. PMID:11123698.
5. De Bernardis, F., Boccanera, M., Rainaldi, L., Guerra, C.E., Quinti, I., and Cassone, A. 1992. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur. J. Epidemiol. 8: 362-367. doi:10.1007/BF00158569. PMID:1356827.
6. De Bernardis, F., Sullivan, P.A., and Cassone, A. 2001. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol. 39: 303-313. doi:10.1080/714031039. PMID:11556759.
7. De Leo, M., Braca, A., De Tommasi, N., Norscia, I., Morelli, I., Battinelli, L., and Mazzanti, G. 2004. Phenolic compounds from Baseonema acuminatum leaves: isolation and antimicrobial activity. Planta Med. 70: 841-846. doi:10.1055/s-2004-827233. PMID:15503354.
8. De Repentigny, L., Aumont, F., Bernard, K., and Belhumeur, P. 2000. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68: 3172-3179. doi:10.1128/IAI.68.6.3172-3179.2000. PMID:10816460.
9. Dostal, J., Pavlickova, L., Soucek, M., Ruml, T., Pichova, I., and Hruskova-Heidingsfeldova, O. 2003. Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. J. Clin. Microbiol. 41: 712-716. doi:10.1128/JCM.41.2.712-716.2003. PMID:12574271.
10. Ghannoum, M.A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13: 122-143. PMID:10627494.
11. Ghannoum, M., and Abu Elteen, K. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24: 407-413. doi:10.1080/02681218680000621. PMID:3537262.
12. Glick, S.D., Maisonneuve, I.M., and Szumlinski, K.K. 2001. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener. Alkaloids Chem. Biol. 56: 39-53. doi:10.1016/S0099-9598(01)56006-X. PMID:11705115.
13. Hube, B., Stehr, F., Bossenz, M., Mazur, A., Kretschmar, M., and Schafer, W. 2000. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch. Microbiol. 174: 362-374. doi:10.1007/s002030000218. PMID:11131027.
14. Hube, B., Hess, D., Baker, C.A., Schaller, M., Schafer, W., and Dolan, J.W. 2001. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology, 147: 879-889. PMID:11283284.
15. Ivanovska, N., Philipov, S., and Hristova, M. 1999. Influence of berberine on T-cell mediated immunity. Immunopharmacol. Immunotoxicol. 21: 771-786. doi:10.3109/08923979909007141. PMID:10584211.
16. Kim, S.Y., Jin, Y.R., Lim, Y., Kim, J.H., Cho, M.R., Hong, J.T., et al. 2005. Inhibition of PDGF β-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol. Planta Med. 71: 599-603. doi:10.1055/s-2005- 871263. PMID:16041643.
17. Lopez-Ribot, J.L., Casanova, M., Gil, M.L., and Martinez, J.P. 1996. Common and form-specific cell wall antigens of Candida albicans as released by chemical and enzymatic treatments. Mycopathologia, 134: 13-20. doi:10.1007/BF00437047. PMID:8817937.
18. Masuoka, J., and Hazen, K.C. 1999. Differences in the acid-labile component of Candida albicans mannan from hydrophobic and hydrophilic yeast cells. Glycobiology, 9: 1281-1286. doi:10.1093/glycob/9.11.1281. PMID:10536044.
19. Masuoka, J., and Hazen, K.C. 2004. Cell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains. Infect. Immun. 72: 6230-6236. doi:10.1128/IAI.72.11.6230-6236.2004. PMID:15501748.
20. Monod, M., and Borg-von Zepelin, M. 2002. Secreted proteinases and other virulence mechanisms of Candida albicans. Chem. Immunol. 81: 114-128. PMID:12101999.
21. Naglik, J.R., Challacombe, S.J., and Hube, B. 2003. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67: 400-428. doi:10.1128/MMBR.67.3.400-428. 2003. PMID:12966142.
22. Niering, P., Michels, G., Watjen, W., Ohler, S., Steffan, B., Chovolou, Y., et al. 2005. Protective and detrimental effects of kaempferol in rat H4IIE cells: implication of oxidative stress and apoptosis. Toxicol. Appl. Pharmacol. 209: 114-122. doi:10.1016/j.taap.2005.04.004. PMID:16112156.
23. Padilla, E., Ruiz, E., Redondo, S., Gordillo-Moscoso, A., Slowing, K., and Tejerina, T. 2005. Relationship between vasodilation capacity and phenolic content of Spanish wines. Eur. J. Pharmacol. 517: 84-91. doi:10.1016/j.ejphar.2005.04.044. PMID:15967426.
24. Yordanov, M., Dimitrova, P., Patkar, S., Falcocchio, S., Xoxi, E., Saso, L., and Ivanovska, N. 2005. Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections. J. Med. Microbiol. 54: 647-653. doi:10.1099/jmm.0.45919-0. PMID:15947429.